ANEW Medical Shares Double After European Patent for Klotho Gene Systems

Dow Jones06-27

By Chris Wack

Shares of ANEW Medical doubled, to $3.80, after the company said it has been granted and issued a patent in Europe for the use of its Klotho gene-sequence and gene-delivery systems.

The biopharmaceutical company said the patent would be used in the treatment of diminished cognition, memory loss, dementia and other neurodegenerative diseases.

ANEW said it licensed this intellectual property on an exclusive worldwide basis from Universitat Autonoma de Barcelona and Institucio Catalana de Recerca i Estudis Avancats in Barcelona.

In March, the company received patent approval in China, and is now approved in Hong Kong as well.

ANEW plans to begin product development and expand their intellectual-property portfolios into the Asian markets beginning in 2024.

Write to Chris Wack at chris.wack@wsj.com

(END) Dow Jones Newswires

June 26, 2024 13:39 ET (17:39 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2446311876?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-06-27 01:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2446311876","market":"hk","top_or_hot":-1,"title":"ANEW Medical Shares Double After European Patent for Klotho Gene Systems","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Chris Wack \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of ANEW Medical doubled, to $3.80, after the company said it has been granted and issued a patent in Europe for the use of its Klotho gene-sequence and gene-delivery systems. \n</p>\n<p>\n  The biopharmaceutical company said the patent would be used in the treatment of diminished cognition, memory loss, dementia and other neurodegenerative diseases. \n</p>\n<p>\n  ANEW said it licensed this intellectual property on an exclusive worldwide basis from Universitat Autonoma de Barcelona and Institucio Catalana de Recerca i Estudis Avancats in Barcelona. \n</p>\n<p>\n  In March, the company received patent approval in China, and is now approved in Hong Kong as well. \n</p>\n<p>\n  ANEW plans to begin product development and expand their intellectual-property portfolios into the Asian markets beginning in 2024. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Chris Wack at chris.wack@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 26, 2024 13:39 ET (17:39 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ANEW Medical Shares Double After European Patent for Klotho Gene Systems</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nANEW Medical Shares Double After European Patent for Klotho Gene Systems\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-06-27 01:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>By Chris Wack \n\n\n \n\n\n  Shares of ANEW Medical doubled, to $3.80, after the company said it has been granted and issued a patent in Europe for the use of its Klotho gene-sequence and gene-delivery ...</p>\n\n<a href=\"https://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OTS.SI","symbol_name":"OTS Holdings","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2446311876","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2446311876","pubTimestamp":1719423540,"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of ANEW Medical doubled, to $3.80, after the company said it has been granted and issued a patent in Europe for the use of its Klotho gene-sequence and gene-delivery systems.The biopharmaceutical company said the patent would be used in the treatment of diminished cognition, memory loss, dementia and other neurodegenerative diseases.ANEW said it licensed this intellectual property on an exclusive worldwide basis from Universitat Autonoma de Barcelona and Institucio Catalana de Recerca i Estudis Avancats in Barcelona.In March, the company received patent approval in China, and is now approved in Hong Kong as well.ANEW plans to begin product development and expand their intellectual-property portfolios into the Asian markets beginning in 2024.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OTS.SI":"OTS Holdings","BK6509":"食品和饮料股","ANEW":"ProShares MSCI Transformational Changes ETF","BK6114":"包装食品与肉类"},"translate_title":"Klotho Gene Systems获得欧洲专利后，ANEW Medical股价翻倍","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ANEW":1,"OTS.SI":1,"WENA":0.9},"content_text":"By Chris Wack \n\n\n \n\n\n  Shares of ANEW Medical doubled, to $3.80, after the company said it has been granted and issued a patent in Europe for the use of its Klotho gene-sequence and gene-delivery systems. \n\n\n  The biopharmaceutical company said the patent would be used in the treatment of diminished cognition, memory loss, dementia and other neurodegenerative diseases. \n\n\n  ANEW said it licensed this intellectual property on an exclusive worldwide basis from Universitat Autonoma de Barcelona and Institucio Catalana de Recerca i Estudis Avancats in Barcelona. \n\n\n  In March, the company received patent approval in China, and is now approved in Hong Kong as well. \n\n\n  ANEW plans to begin product development and expand their intellectual-property portfolios into the Asian markets beginning in 2024. \n\n\n \n\n\n  Write to Chris Wack at chris.wack@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 26, 2024 13:39 ET (17:39 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.28.3","shortVersion":"4.28.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2446311876"}